PRDX1 and pancreatic ductal adenocarcinoma: Overexpression and the oncogenic function of PRDX1 were demonstrated in many cancers, including breast cancer [56], non-small-cell lung carcinoma [57], pancreatic ductal adenocarcinoma (PDAC) [58], and colorectal cancer [59].